Literature DB >> 16736450

Doppler echocardiographic and electrocardiographic atrioventricular time intervals in newborn infants: evaluation of techniques for surveillance of fetuses at risk for congenital heart block.

G Bergman1, L-A Jacobsson, M Wahren-Herlenius, S-E Sonesson.   

Abstract

OBJECTIVE: To evaluate one novel and two previously reported Doppler flow velocimetric techniques to estimate atrioventricular (AV) time intervals, suggested to be useful for early identification of fetuses at risk for congenital heart block.
METHODS: In 22 newborn infants, Doppler tracings were obtained from the mitral valve/aortic outflow and the superior vena cava/ascending aorta, as an ECG was recorded simultaneously. AV time intervals were measured using the onsets of the mitral A-wave/aortic outflow (MV-Ao), superior vena cava a-wave/aortic flow (SVC-Ao), and mitral A-wave/mitral valve closure (MV) as indirect markers of electrical atrial/ventricular activation.
RESULTS: Close positive linear relationships to the electrocardiographic PR interval were demonstrated for the MV-Ao (r = 0.82, S(y/x) = 7.4 ms), SVC-Ao (r = 0.85, S(y/x) = 6.8 ms), and MV (r = 0.92, S(y/x) = 3.8 ms) approaches. Both techniques using the aortic flow to indicate ventricular activation overestimated the PR interval: the MV-Ao by + 32 +/- 7.7 ms (mean +/- SD) and the SVC-Ao approach by + 22 +/- 7.0 ms. The new MV approach using mitral closure for the same purpose did not overestimate the PR interval, but there was a trend towards underestimation of the PR intervals as time intervals increased.
CONCLUSIONS: When systematic differences between echocardiographic and electrocardiographic AV time intervals are compensated for, all three techniques are useful to get indirect estimates of the PR interval. As MV recordings only need insonation of a single valve, and are thus easier to obtain, this technique may be of value as a first screening method to identify fetuses in need for further surveillance. In cases with AV time prolongation the SVC-Ao method seems superior. 2006 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16736450     DOI: 10.1002/uog.2712

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  8 in total

Review 1.  Finding the "PR-fect" solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease?

Authors:  Colin K L Phoon; Mimi Y Kim; Jill P Buyon; Deborah M Friedman
Journal:  Congenit Heart Dis       Date:  2012-04-12       Impact factor: 2.007

Review 2.  Overview of fetal arrhythmias.

Authors:  Shardha Srinivasan; Janette Strasburger
Journal:  Curr Opin Pediatr       Date:  2008-10       Impact factor: 2.856

Review 3.  Perinatal arrhythmias: diagnosis and management.

Authors:  Janette F Strasburger; Bageshree Cheulkar; Heather J Wichman
Journal:  Clin Perinatol       Date:  2007-12       Impact factor: 3.430

Review 4.  Atrioventricular block during fetal life.

Authors:  Lindsey E Hunter; John M Simpson
Journal:  J Saudi Heart Assoc       Date:  2014-07-10

Review 5.  Fetal cardiac arrhythmias: Current evidence.

Authors:  Nathalie Jeanne Bravo-Valenzuela; Luciane Alves Rocha; Luciano Marcondes Machado Nardozza; Edward Araujo Júnior
Journal:  Ann Pediatr Cardiol       Date:  2018 May-Aug

Review 6.  Autoimmune Congenital Heart Block: A Review of Biomarkers and Management of Pregnancy.

Authors:  Sara De Carolis; Cristina Garufi; Ester Garufi; Maria Pia De Carolis; Angela Botta; Sara Tabacco; Silvia Salvi
Journal:  Front Pediatr       Date:  2020-12-22       Impact factor: 3.418

7.  The transverse four-chamber view for the assessment of atrial tissue deformation in the fetus.

Authors:  Johannes Steinhard; Andreas Entenmann; Elise van der Valk; Ralf Schmitz; Jörg Heinig; Kai Thorsten Laser; Miriam Michel
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

8.  Morphine-induced supraventricular tachycardia in near-term fetus.

Authors:  Vincenzo Zanardo; Alphonse Simbi; Matteo Parotto; Lorenzo Severino; Riccardo Carta; Pietro Guerrini; Gianluca Straface
Journal:  Ital J Pediatr       Date:  2018-09-24       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.